Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.37 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.33 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.32 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.32 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.30 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.30 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346150 | 0.81 | PDE5A (0.37) | KMOIP6K1MDM2FTOPARP1 | |
| SCHEMBL31346153 | 0.81 | PDE5A (0.37) | KMOIP6K1MDM2FTOPARP1 | |
| SCHEMBL31346035 | 0.80 | SLC6A2 (0.36) | KMOMDM2PARP1SLC6A2 | |
| SCHEMBL31346141 | 0.75 | EZH2 (0.38) | EZH2 | |
| SCHEMBL31346159 | 0.73 | RORC (0.35) | MDM2PARP1 | |
| SCHEMBL31346157 | 0.73 | RORC (0.35) | MDM2PARP1 | |
| SCHEMBL31346161 | 0.73 | RORC (0.35) | MDM2PARP1 | |
| SCHEMBL31346087 | 0.72 | EZH2 (0.36) | EZH2 | |
| SCHEMBL31346107 | 0.69 | CNR1 (0.37) | KMOIP6K1MDM2SLC6A2 | |
| SCHEMBL31346081 | 0.69 | EZH2 (0.33) | EZH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |